Perpetual Ltd Sells 1,233,103 Shares of Henry Schein, Inc. (NASDAQ:HSIC)

Perpetual Ltd lowered its stake in shares of Henry Schein, Inc. (NASDAQ:HSIC - Free Report) by 51.7% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 1,149,815 shares of the company's stock after selling 1,233,103 shares during the quarter. Perpetual Ltd owned approximately 0.90% of Henry Schein worth $83,822,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors have also modified their holdings of the stock. Vanguard Group Inc. grew its position in shares of Henry Schein by 1.7% during the first quarter. Vanguard Group Inc. now owns 15,432,001 shares of the company's stock worth $1,165,425,000 after acquiring an additional 260,537 shares during the last quarter. American Century Companies Inc. grew its position in shares of Henry Schein by 3.1% in the second quarter. American Century Companies Inc. now owns 5,484,286 shares of the company's stock valued at $351,543,000 after purchasing an additional 162,477 shares during the last quarter. Swedbank AB purchased a new position in Henry Schein during the first quarter worth $215,998,000. Nuance Investments LLC grew its holdings in shares of Henry Schein by 6.2% during the second quarter. Nuance Investments LLC now owns 1,863,333 shares of the company's stock worth $119,440,000 after buying an additional 108,143 shares in the last quarter. Finally, Burgundy Asset Management Ltd. grew its position in shares of Henry Schein by 1.0% in the second quarter. Burgundy Asset Management Ltd. now owns 1,640,379 shares of the company's stock valued at $105,148,000 after purchasing an additional 16,476 shares during the period. Hedge funds and other institutional investors own 96.62% of the company's stock.

Wall Street Analyst Weigh In

HSIC has been the subject of several research reports. Barrington Research reissued an "outperform" rating and set a $82.00 price objective on shares of Henry Schein in a research note on Friday, September 20th. Piper Sandler restated an "overweight" rating and issued a $86.00 price objective on shares of Henry Schein in a report on Friday, June 21st. Robert W. Baird reduced their price objective on Henry Schein from $92.00 to $82.00 and set an "outperform" rating on the stock in a research note on Wednesday, August 7th. Evercore ISI increased their target price on shares of Henry Schein from $70.00 to $74.00 and gave the stock an "in-line" rating in a research report on Tuesday. Finally, Baird R W raised shares of Henry Schein from a "hold" rating to a "strong-buy" rating in a research report on Monday, July 22nd. One equities research analyst has rated the stock with a sell rating, six have issued a hold rating, five have assigned a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat.com, the company has an average rating of "Hold" and a consensus target price of $77.50.

Henry Schein Stock Performance

NASDAQ:HSIC traded down $0.47 during midday trading on Thursday, reaching $70.04. 684,231 shares of the company traded hands, compared to its average volume of 1,336,822. The company has a debt-to-equity ratio of 0.46, a current ratio of 1.55 and a quick ratio of 0.90. Henry Schein, Inc. has a twelve month low of $60.01 and a twelve month high of $82.63. The company has a fifty day moving average price of $70.03 and a 200 day moving average price of $70.02. The firm has a market capitalization of $8.97 billion, a price-to-earnings ratio of 23.82, a price-to-earnings-growth ratio of 2.01 and a beta of 0.86.

Henry Schein (NASDAQ:HSIC - Get Free Report) last released its earnings results on Tuesday, August 6th. The company reported $1.23 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.22 by $0.01. Henry Schein had a return on equity of 13.19% and a net margin of 2.82%. The firm had revenue of $3.10 billion for the quarter, compared to analyst estimates of $3.27 billion. During the same period in the previous year, the company earned $1.31 earnings per share. Henry Schein's revenue was up .0% compared to the same quarter last year. On average, analysts expect that Henry Schein, Inc. will post 4.74 EPS for the current fiscal year.

Insider Transactions at Henry Schein

In other Henry Schein news, SVP Lorelei Mcglynn sold 21,035 shares of the company's stock in a transaction dated Friday, September 6th. The shares were sold at an average price of $69.30, for a total transaction of $1,457,725.50. Following the completion of the sale, the senior vice president now directly owns 71,833 shares of the company's stock, valued at approximately $4,978,026.90. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Corporate insiders own 1.14% of the company's stock.

Henry Schein Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.